These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1336043)

  • 1. Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.
    Kelsey SM; Weinhardt B; Pocock CE; Shaw E; Newland AC
    J Chemother; 1992 Oct; 4(5):281-5. PubMed ID: 1336043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients.
    Fleischhack G; Schmidt-Niemann M; Wulff B; Havers W; Marklein G; Hasan C; Bode U
    Support Care Cancer; 2001 Jul; 9(5):372-9. PubMed ID: 11497392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies.
    Hazel DL; Graham J; Dickinson JP; Newland AC; Kelsey SM
    J Chemother; 1997 Aug; 9(4):267-72. PubMed ID: 9269607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I;
    J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.
    Leyland MJ; Bayston KF; Cohen J; Warren R; Newland AC; Bint AJ; Cefai C; White DG; Murray SA; Bareford D
    J Antimicrob Chemother; 1992 Dec; 30(6):843-54. PubMed ID: 1289359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
    Kelsey SM; Shaw E; Newland AC
    J Chemother; 1992 Apr; 4(2):107-13. PubMed ID: 1629747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.
    Kelsey SM; Weinhardt B; Collins PW; Newland AC
    Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):509-14. PubMed ID: 1388120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
    Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
    Kelsey SM; Collins PW; Delord C; Weinhard B; Newland AC
    Br J Haematol; 1990 Dec; 76 Suppl 2():10-3. PubMed ID: 2149044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
    Gorschlüter M; Hahn C; Fixson A; Mey U; Ziske C; Molitor E; Horré R; Sauerbruch T; Marklein G; Schmidt-Wolf IG; Glasmacher A
    Support Care Cancer; 2003 Jun; 11(6):362-70. PubMed ID: 12690546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Rizal AM; Nordiah AJ; Jamal R
    Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia.
    Bauduer F; Cousin T; Boulat O; Rigal-Huguet F; Molina L; Fegueux N; Jourdan E; Boiron JM; Reiffers J;
    Leuk Lymphoma; 2001 Jul; 42(3):379-86. PubMed ID: 11699402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
    Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.
    Le Guyader N; Auvrignon A; Vu-Thien H; Portier E; Tabone MD; Leverger G
    Support Care Cancer; 2004 Oct; 12(10):720-4. PubMed ID: 15138864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
    Sato T; Kobayashi R; Yasuda K; Kaneda M; Iguchi A; Kobayashi K
    Pediatr Blood Cancer; 2008 Dec; 51(6):774-7. PubMed ID: 18661495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.